DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» VP40
VP40
Ebola Virus VP40 Real-Time RT-PCR Assay for Use Under an Emergency Use Authorization Only
WHO Expert Committee on Biological Standardization: Sixty-Eighth Report (WHO Technical Report Series, No
Virus-Host Interaction: the Multifaceted Roles of Ifitms And
A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
Defining the Multiplicity and Type of Infection for the Production of Zaire Ebola Virus-Like Particles in the Insect Cell Baculovirus Expression System
Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle
Defining the Multiplicity and Time of Infection for the Production of Zaire
Low-Level Ionizing Radiation Induces Selective Killing of HIV-1-Infected Cells with Reversal of Cytokine Induction Using Mtor Inhibitors
Mrna Vaccines for Infectious Diseases: Principles, Delivery and Clinical Translation
Vesicular Release of Ebola Virus Matrix Protein VP40
Role of the C-Terminal Region of Vervet Monkey Polyomavirus 1 VP1 in Virion Formation
HIV-1 and Ebola Virus Encode Small Peptide Motifs That Recruit Tsg101 to Sites of Particle Assembly to Facilitate Egress
For Use Under the Emergency Use Authorization Only for in Vitro Diagnostic Use for Prescription Use Only STORAGE: Store at 2 to 30°C (36 to 86°F)
696 Matrix Proteins As Centralized Organizers of Negative-Sens
SARS-Cov-2 Envelope (E) Protein Interacts with PDZ-Domain-2 of Host Tight Junction Protein
Research.Pdf (4.530Mb)
Ubiquitin and Ubiquitin-Like Modifications in Viral Infection and Immunity
Regulation of Ebola Virus VP40 Matrix Protein by SUMO Maite Baz-Martínez1, Ahmed El Motiam1, Paula Ruibal2,3, Gabriela N
Top View
TIM-Family Proteins Inhibit HIV-1 Release PNAS PLUS
Plant-Derived Antimicrobial Peptides As Potential Antiviral Agents in Systemic Viral Infections
Evolutionary Trends in Viral Pathogens Within and Between Outbreaks
Structure of the Ebola Virus Envelope Protein MPER/TM Domain and Its
Exosome-Based Vaccines: Pros and Cons in the World of Animal Health
Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction Michelle Pleet
Identification of a Novel Viral Protein Expressed from the PB2 Segment
Function of the Viral Matrix Proteins VP40 and VP24 for the Life Cycle of Ebola Virus
Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats
Cysteine Mutations in the Ebolavirus Matrix Protein VP40 Promote Phosphatidylserine Binding by Increasing the Flexibility of a Lipid-Binding Loop
Metabolites OH
Review Eview
Identification of Novel Virus from Vervet Monkey in Zambia and Analysis of Its Viral Assembly
The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
Antibody Licensing and Abreviews
Coronavirus Envelope Protein: Current Knowledge Dewald Schoeman and Burtram C
Tat RNA Silencing Suppressor Activity Contributes to Perturbation Of
Paramyxovirus Glycoprotein Incorporation, Assembly and Budding: a Three Way Dance for Infectious Particle Production
Modeling of the Ebola Virus Delta Peptide Reveals a Potential Lytic Sequence Motif
Viral Structures and Antibodies
Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP
A Review of Functional Motifs Utilized by Viruses
Crystal Structure of the Borna Disease Virus Matrix Protein (BDV-M) Reveals Ssrna Binding Properties
( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0345831 A1 THESS Et Al
Modelling the Effects of Disease-Associated Single Amino
PRODUCTION OPTIMIZATION of ROTAVIRUS- LIKE PARTICLES António Manuel Missionário Roldão
Mutation of Ebola Virus Matrix Protein Cysteine Residues Increases Binding to Phosphatidylserine Through Increased Flexibility of a Lipid Binding Loop
Association of Rotavirus Viroplasms with Microtubules Through NSP2 and NSP5 Claudio Cabral-Romero, Luis Padilla-Noriega+
Structure and Assembly of a Paramyxovirus Matrix Protein